Involved field radiation for Hodgkin's lymphoma: The actual dose to breasts in close proximity

Bouthaina Dabaja, Zhonglu Wang, Marilyn Stovall, Jamie S. Baker, Susan A. Smith, Meena Khan, Leslie Ballas, Mohammad R. Salehpour

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

To decrease the risk of late toxicities in Hodgkin's lymphoma (HL) patients treated with radiation therapy (RT) (HL), involved field radiation therapy (IFRT) has largely replaced the extended fields. To determine the out-of-field dose delivered from a typical IFRT to surrounding critical structures, we measured the dose at various points in an anthropomorphic phantom. The phantom is divided into 1-inch-thick slices with the ability to insert TLDs at 3-cm intervals grid spacing. Two treatment fields were designed, and a total of 45 TLDs were placed (equally spaced) at the margin of the each of the 2 radiation fields. After performing a computed tomography simulation, 2 treatment plans targeting the mediastinum, a typical treatment field in patients with early stage HL, were generated. A total dose of 3060 cGy was delivered to the gross tumor volume for each field consecutively. The highest measured dose detected at 1 cm from the field edge in the planning target volume was 496 cGy, equivalent to 16% of the isocentric dose. The dose dropped significantly with increasing distance from the field edge. It ranged from 1.1-3.9% of the isocentric dose at a distance of 3.2-4 cm to <1.6% at a distance of >6 cm. Although the computer treatment planning system (CTPS) frequently underestimated the dose delivered, the difference in dose between measured and generated by CTPS was <2.5% in 90 positions measured. The collateral dose of radiation to breasts from IFRT is minimal. The out-of-field dose, although mildly underestimated by CTPS, becomes insignificant at >3 cm from the field edge of the radiation field.

Original languageEnglish (US)
Pages (from-to)374-382
Number of pages9
JournalMedical Dosimetry
Volume37
Issue number4
DOIs
StatePublished - Apr 16 2012

Fingerprint

Hodgkin Disease
Breast
Radiation
Radiotherapy
Therapeutics
Mediastinum
Tumor Burden
Tomography

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Dabaja, B., Wang, Z., Stovall, M., Baker, J. S., Smith, S. A., Khan, M., ... Salehpour, M. R. (2012). Involved field radiation for Hodgkin's lymphoma: The actual dose to breasts in close proximity. Medical Dosimetry, 37(4), 374-382. https://doi.org/10.1016/j.meddos.2012.02.003
Dabaja, Bouthaina ; Wang, Zhonglu ; Stovall, Marilyn ; Baker, Jamie S. ; Smith, Susan A. ; Khan, Meena ; Ballas, Leslie ; Salehpour, Mohammad R. / Involved field radiation for Hodgkin's lymphoma : The actual dose to breasts in close proximity. In: Medical Dosimetry. 2012 ; Vol. 37, No. 4. pp. 374-382.
@article{eba1025856e349cb8982ca4e88e85137,
title = "Involved field radiation for Hodgkin's lymphoma: The actual dose to breasts in close proximity",
abstract = "To decrease the risk of late toxicities in Hodgkin's lymphoma (HL) patients treated with radiation therapy (RT) (HL), involved field radiation therapy (IFRT) has largely replaced the extended fields. To determine the out-of-field dose delivered from a typical IFRT to surrounding critical structures, we measured the dose at various points in an anthropomorphic phantom. The phantom is divided into 1-inch-thick slices with the ability to insert TLDs at 3-cm intervals grid spacing. Two treatment fields were designed, and a total of 45 TLDs were placed (equally spaced) at the margin of the each of the 2 radiation fields. After performing a computed tomography simulation, 2 treatment plans targeting the mediastinum, a typical treatment field in patients with early stage HL, were generated. A total dose of 3060 cGy was delivered to the gross tumor volume for each field consecutively. The highest measured dose detected at 1 cm from the field edge in the planning target volume was 496 cGy, equivalent to 16{\%} of the isocentric dose. The dose dropped significantly with increasing distance from the field edge. It ranged from 1.1-3.9{\%} of the isocentric dose at a distance of 3.2-4 cm to <1.6{\%} at a distance of >6 cm. Although the computer treatment planning system (CTPS) frequently underestimated the dose delivered, the difference in dose between measured and generated by CTPS was <2.5{\%} in 90 positions measured. The collateral dose of radiation to breasts from IFRT is minimal. The out-of-field dose, although mildly underestimated by CTPS, becomes insignificant at >3 cm from the field edge of the radiation field.",
author = "Bouthaina Dabaja and Zhonglu Wang and Marilyn Stovall and Baker, {Jamie S.} and Smith, {Susan A.} and Meena Khan and Leslie Ballas and Salehpour, {Mohammad R.}",
year = "2012",
month = "4",
day = "16",
doi = "10.1016/j.meddos.2012.02.003",
language = "English (US)",
volume = "37",
pages = "374--382",
journal = "Medical Dosimetry",
issn = "0958-3947",
publisher = "Elsevier Inc.",
number = "4",

}

Dabaja, B, Wang, Z, Stovall, M, Baker, JS, Smith, SA, Khan, M, Ballas, L & Salehpour, MR 2012, 'Involved field radiation for Hodgkin's lymphoma: The actual dose to breasts in close proximity', Medical Dosimetry, vol. 37, no. 4, pp. 374-382. https://doi.org/10.1016/j.meddos.2012.02.003

Involved field radiation for Hodgkin's lymphoma : The actual dose to breasts in close proximity. / Dabaja, Bouthaina; Wang, Zhonglu; Stovall, Marilyn; Baker, Jamie S.; Smith, Susan A.; Khan, Meena; Ballas, Leslie; Salehpour, Mohammad R.

In: Medical Dosimetry, Vol. 37, No. 4, 16.04.2012, p. 374-382.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Involved field radiation for Hodgkin's lymphoma

T2 - The actual dose to breasts in close proximity

AU - Dabaja, Bouthaina

AU - Wang, Zhonglu

AU - Stovall, Marilyn

AU - Baker, Jamie S.

AU - Smith, Susan A.

AU - Khan, Meena

AU - Ballas, Leslie

AU - Salehpour, Mohammad R.

PY - 2012/4/16

Y1 - 2012/4/16

N2 - To decrease the risk of late toxicities in Hodgkin's lymphoma (HL) patients treated with radiation therapy (RT) (HL), involved field radiation therapy (IFRT) has largely replaced the extended fields. To determine the out-of-field dose delivered from a typical IFRT to surrounding critical structures, we measured the dose at various points in an anthropomorphic phantom. The phantom is divided into 1-inch-thick slices with the ability to insert TLDs at 3-cm intervals grid spacing. Two treatment fields were designed, and a total of 45 TLDs were placed (equally spaced) at the margin of the each of the 2 radiation fields. After performing a computed tomography simulation, 2 treatment plans targeting the mediastinum, a typical treatment field in patients with early stage HL, were generated. A total dose of 3060 cGy was delivered to the gross tumor volume for each field consecutively. The highest measured dose detected at 1 cm from the field edge in the planning target volume was 496 cGy, equivalent to 16% of the isocentric dose. The dose dropped significantly with increasing distance from the field edge. It ranged from 1.1-3.9% of the isocentric dose at a distance of 3.2-4 cm to <1.6% at a distance of >6 cm. Although the computer treatment planning system (CTPS) frequently underestimated the dose delivered, the difference in dose between measured and generated by CTPS was <2.5% in 90 positions measured. The collateral dose of radiation to breasts from IFRT is minimal. The out-of-field dose, although mildly underestimated by CTPS, becomes insignificant at >3 cm from the field edge of the radiation field.

AB - To decrease the risk of late toxicities in Hodgkin's lymphoma (HL) patients treated with radiation therapy (RT) (HL), involved field radiation therapy (IFRT) has largely replaced the extended fields. To determine the out-of-field dose delivered from a typical IFRT to surrounding critical structures, we measured the dose at various points in an anthropomorphic phantom. The phantom is divided into 1-inch-thick slices with the ability to insert TLDs at 3-cm intervals grid spacing. Two treatment fields were designed, and a total of 45 TLDs were placed (equally spaced) at the margin of the each of the 2 radiation fields. After performing a computed tomography simulation, 2 treatment plans targeting the mediastinum, a typical treatment field in patients with early stage HL, were generated. A total dose of 3060 cGy was delivered to the gross tumor volume for each field consecutively. The highest measured dose detected at 1 cm from the field edge in the planning target volume was 496 cGy, equivalent to 16% of the isocentric dose. The dose dropped significantly with increasing distance from the field edge. It ranged from 1.1-3.9% of the isocentric dose at a distance of 3.2-4 cm to <1.6% at a distance of >6 cm. Although the computer treatment planning system (CTPS) frequently underestimated the dose delivered, the difference in dose between measured and generated by CTPS was <2.5% in 90 positions measured. The collateral dose of radiation to breasts from IFRT is minimal. The out-of-field dose, although mildly underestimated by CTPS, becomes insignificant at >3 cm from the field edge of the radiation field.

UR - http://www.scopus.com/inward/record.url?scp=84868200543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868200543&partnerID=8YFLogxK

U2 - 10.1016/j.meddos.2012.02.003

DO - 10.1016/j.meddos.2012.02.003

M3 - Article

C2 - 22513213

AN - SCOPUS:84868200543

VL - 37

SP - 374

EP - 382

JO - Medical Dosimetry

JF - Medical Dosimetry

SN - 0958-3947

IS - 4

ER -